After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Quince Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Quince Therapeutics Inc is $81.26M. A total of 1.05 million shares were traded on the day, compared to an average of 509.26K shares.
In the most recent transaction, Thye Dirk bought 77,000 shares of QNCX for 0.70 per share on Aug 30 ’24. After the transaction, the CEO AND CHIEF MEDICAL OFFICER now owns 843,941 company shares. In a previous transaction on Aug 29 ’24, Thye Dirk bought 77,500 shares at 0.69 per share. QNCX shares that CEO AND CHIEF MEDICAL OFFICER owns now total 766,941.
Among the insiders who bought shares, Ryan Charles S. acquired of 48,387 shares on Aug 20 ’24 at a per-share price of $0.65. This resulted in the PRESIDENT holding 122,461 shares of QNCX after the transaction. In another insider transaction, Hannah Brendan bought 30,845 shares at $0.63 per share on Aug 21 ’24. Company shares held by the CHIEF BUSINESS OFFICER AND COO now total 296,540.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, QNCX has a high of $2.14 and a low of $0.51.
As of this writing, QNCX has an earnings estimate of -$0.1 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of -$0.1 per share and a lower estimate of -$0.1.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. QNCX’s latest balance sheet shows that the firm has $106.80M in Cash & Short Term Investments as of fiscal 2021. There were $1.16M in debt and $14.22M in liabilities at the time. Its Book Value Per Share was $1.04, while its Total Shareholder’s Equity was $118.59M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for QNCX is Buy with a score of 5.00.
